株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

イオンチャネルモジュレーターの世界市場

Ion Channel Modulators

発行 Global Industry Analysts, Inc. 商品コード 269629
出版日 ページ情報 英文 151 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
イオンチャネルモジュレーターの世界市場 Ion Channel Modulators
出版日: 2019年05月01日 ページ情報: 英文 151 Pages
概要

当レポートでは、世界のイオンチャネルモジュレータ市場について調査し、市場の概要と競合動向、製品概要、地域別の動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 見通し
    • イオンチャネルモジュレータ:後退する市場
    • 現在および将来分析
    • 高齢化
    • 競合シナリオ
    • 特許失効
  • 業界概要
    • イオンチャネル:タイプ、機能的使用、多様性
    • 現在入手可能なイオンチャネルモジュレータ薬剤
    • 作用機序別薬剤
    • 治療適応別イオンチャネルモジュレータ
    • イオンチャネルモジュレータのアウトソーシングへの関心の高まり
    • サブタイプに対する選択制 他
  • 製品概要
    • イオンチャネルモジュレータ:イントロダクション
    • イオンチャネルの生物学的重要性
    • 疾患治療選択肢としてのイオンチャネルモジュレータ
    • イオンチャネルの種類 他
  • 近年の業界活動
  • 主要企業
    • Allergan plc
    • AstraZeneca
    • Bayer HealthCare Pharmaceuticals
    • Biogen, Inc.
    • GlaxoSmithKline Plc.
    • H. Lundbeck A/S
    • Johnson & Johnson
    • Novartis AG
    • Parion Sciences, Inc.
    • Pfizer, Inc.
    • Sanofi S.A.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • その他の諸国
目次
Product Code: MCP-6940

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 39 companies including many key and niche players such as -

Allergan plc
AstraZeneca
Bayer HealthCare Pharmaceuticals
Biogen, Inc.
GlaxoSmithKline Plc
H. Lundbeck A/S

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Ion Channel Modulators - A Receding Market
  • Current and Future Analysis
  • Aging Population: Creating Need for More Efficient and Safe Drugs
    • Table 1: Global Population Worldwide: Percentage Share Breakdown by Age Group for the year 2025 (includes corresponding Graph/Chart)
    • Table 2: Global Population of People Aged 65+ Years (In Million) for the Years 2012, 2020 & 2050 (includes corresponding Graph/Chart)
  • Competitive Scenario
    • Table 3: Leading Ion Channel Modulators Worldwide: 2016 (Percentage Breakdown of Revenues) (includes corresponding Graph/Chart)
  • Patent Expiries of Select Ion Channel Modulators

2. INDUSTRY OVERVIEW

  • Ion Channels - A Peek into Their Types, Functional Use and Diversity
  • Ion Channels - Difficult Drug Targets
  • Currently Available Ion Channel Modulating Drugs in the Market
  • Select Ion Channel Modulator Drugs by Mode of Action
  • Ion Channel Modulators by Therapeutic Indication
  • Cardiovascular Diseases/ Hypertension
    • Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
    • Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
  • Arrhythmia Treatment
  • Convulsions
  • Pain Management
  • Oncology
  • Diabetes
  • Ion Channel Modulation of Antiemetics
  • Ion Channel Modulators Find Extensive Use in Neglected Tropical Diseases
  • Other Therapeutic Areas
  • Ion Channel Screening Aided by APC
  • Growing Interest in Outsourcing of Ion Channel Services
  • Selectivity against Subtypes - Need of the Hour for Na Channel Blockers
  • Select First Gen Sodium Ion Channel Modulators and Indications
  • Sodium Channel Subtypes, Specific Tissues and Indications
  • Strong Potential Na Channel Blockers for Use in Neuropathic Pain
  • New Trial Questions Nifedipine's Use for Treating Chronic Chilblains

3. PRODUCT OVERVIEW

  • Ion Channel Modulators: An Introduction
  • Biological Significance of Ion Channels
  • Ion Channel Modulators as an Option for Treating Diseases
  • Types of Ion Channels
  • Voltage-Gated Ion Channels
  • Extracellular Ligand-gated Ion Channels
  • Intracellular Ligand-gated Ion Channels

4. RECENT INDUSTRY ACTIVITY

  • Xenon Pharmaceuticals Begins Phase I Trials on XEN1101 Potassium Channel Opener
  • AstraZeneca Inks Agreement with Aspen for Residual Rights to its Anesthetics Portfolio
  • Parion Grants Global Rights for P-321 to Shire
  • Xenon Adds XEN1101 Potassium Channel Modulator to Its Pipeline
  • Alvogen Recalls 24 Lots of Nifedipine
  • Parion Commences Phase II Clinical Trial of P-321
  • AstraZeneca Sells Rights of Anesthetics to Aspen
  • AstraZeneca Inks Licensing Deal with CMS
  • Evotec and Asahi Collaborate for Screening of Ion Channel Targets
  • Catalyst Merges with Targacept
  • XRpro Acquires Pfizer's Ion Channel Biology Platform
  • Vertex and Parion Team Up to Develop ENaC Inhibitors
  • Parion Initiates Enrollment for Phase II Clinical Trial for P-1037 in Cystic Fibrosis
  • Biogen Idec Changes Name to Biogen
  • Biogen Idec Acquires Convergence Pharmaceuticals
  • Pfizer Wins Court Ruling to Block Generic Versions of Lyrica Upto 2018
  • Forest Labs Discontinues Namenda 5/10 mg Tablets, Launches Namenda XR
  • Forest Files Lawsuit against Namenda Generic Manufacturers
  • Cytocentrics Bioscience Selects Drug Safety Testing Center as its Distributor in Japanese Market
  • Zalicus Licenses Its Entire Sodium Channel Modulator Program to AnaBios Corporation
  • EPIRUS Merges with Zalicus

5. FOCUS ON SELECT GLOBAL PLAYERS

  • Allergan plc (Ireland)
  • AstraZeneca (UK)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Biogen, Inc. (USA)
  • GlaxoSmithKline Plc. (UK)
  • H. Lundbeck A/S (Denmark)
  • Johnson & Johnson (USA)
  • Novartis AG (Switzerland)
  • Parion Sciences, Inc. (USA)
  • Pfizer, Inc. (USA)
  • Sanofi S.A. (France)

6. GLOBAL MARKET PERSPECTIVE

    • Table 9: World Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 10: World 8-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 11: The US Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 12: Canadian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 13: Japanese Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4. EUROPE

  • Market Analysis
    • Table 14: European Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 15: European 8-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Sanofi S.A. - A Key Player
  • B. Market Analytics
    • Table 16: French Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Bayer HealthCare Pharmaceuticals - A Key German Player in the Ion Channel Modulator Market
  • B. Market Analytics
    • Table 17: German Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 18: Italian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 19: The UK Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 20: Spanish Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 21: Russian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 22: Rest of Europe Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 23: Asia-Pacific Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 24: Rest of World Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Back to Top